数据来源： BC CDC http://www.bccdc.ca/Health-Info-Site/Documents/COVID_sitrep/2021-07-26_Data_Summary.pdf • Most of the cases, hospitalizations and deaths over the past month were among unvaccinated individuals. Severe outcomes are less common among fully vaccinated people (5%). 过去一个月中，住院和死亡主要来自没接种疫苗的， 5% 来自完全接种的。 • Vaccine coverage in BC, July 20th: ~90% of 70+ and ~80% of 12+ have received their 1st dose; almost 50% of the total population has received their 2nd dose. 70 岁以上， 90% 打了第一针， 12 岁以上， 80% 打了第一针；接近 50% 打了两针 • The share of VOCs among all positive tests in BC is ~97% from July 11 to 17; P.1 (Gamma) ~42% and B.1.617 (Delta) ~41% are now two dominant VOCs, followed by B.1.1.7 (Alpha) at ~18%. 97% 病例来自3 个变种, Gamma 42%, Delta 41%, Alpha 18% 链接有全文，大家自己看。 其中两个图非常有意思： 图1： 完全接种的50% 只占各种病例的 5% 左右 图二：完全接种后死亡的， 平均年龄 96 岁
回复 10楼vitd120的帖子 During the blinded, controlled period, 15 BNT162b2 and 14 placebo recipients died; during the open-label period, 3 BNT162b2 and 2 original placebo recipients who received BNT162b2 after unblinding died. None of these deaths were considered related to BNT162b2 by investigators. Causes of death were balanced between BNT162b2 and placebo groups (Table S4). 你误解了吧。 这里说的是和 trial 无关的死亡，两边差不多是应该的
During the blinded, controlled period, 15 BNT162b2 and 14 placebo recipients died; during the open-label period, 3 BNT162b2 and 2 original placebo recipients who received BNT162b2 after unblinding died. None of these deaths were considered related to BNT162b2 by investigators. Causes of death were balanced between BNT162b2 and placebo groups (Table S4).
回复 10楼vitd120的帖子 During the blinded, controlled period, 15 BNT162b2 and 14 placebo recipients died; during the open-label period, 3 BNT162b2 and 2 original placebo recipients who received BNT162b2 after unblinding died. None of these deaths were considered related to BNT162b2 by investigators. Causes of death were balanced between BNT162b2 and placebo groups (Table S4). 你误解了吧。 这里说的是和 trial 无关的死亡，两边差不多是应该的 dcbby 发表于 2021-07-28 15:46
• Most of the cases, hospitalizations and deaths over the past month were among unvaccinated individuals. Severe outcomes are less common among fully vaccinated people (5%). 过去一个月中，住院和死亡主要来自没接种疫苗的， 5% 来自完全接种的。
• Vaccine coverage in BC, July 20th: ~90% of 70+ and ~80% of 12+ have received their 1st dose; almost 50% of the total population has received their 2nd dose. 70 岁以上， 90% 打了第一针， 12 岁以上， 80% 打了第一针；接近 50% 打了两针
• The share of VOCs among all positive tests in BC is ~97% from July 11 to 17; P.1 (Gamma) ~42% and B.1.617 (Delta) ~41% are now two dominant VOCs, followed by B.1.1.7 (Alpha) at ~18%. 97% 病例来自3 个变种, Gamma 42%, Delta 41%, Alpha 18%
链接有全文，大家自己看。 其中两个图非常有意思： 图1： 完全接种的50% 只占各种病例的 5% 左右
图二：完全接种后死亡的， 平均年龄 96 岁
这属于魔症了吧，fully vaccinated只死了一个，结果你说不行样本太少。。。合着死的少了反而是疫苗的缺点了？
太搞笑了
刚刚在看今天trial里的结果，每组各22000个人，疫苗组死15个，非疫苗组14个
一共21个人死了，其中只有一个打了两针疫苗。20 vs 1，还嫌smaple size 小？
你误会了，我说的是用一个样本，代表一组数据，来支持一个结论（这个大标题），统计上不妥
是的， 吸引一下眼球。
打完了的平均住院年龄 81， 没打的52， 这个有没有统计意义？
数据来源？
https://www.medrxiv.org/content/10.1101/2021.07.28.21261159v1
我想层主的意思是完全接种中死亡平均年龄 96 这个没意义，我同意。
但完全接种降低死亡这个应该是明显的。
是的，谢谢！ 侧面证明疫苗有用，只有免疫力极度有限的老年人受影响
During the blinded, controlled period, 15 BNT162b2 and 14 placebo recipients died; during the open-label period, 3 BNT162b2 and 2 original placebo recipients who received BNT162b2 after unblinding died. None of these deaths were considered related to BNT162b2 by investigators. Causes of death were balanced between BNT162b2 and placebo groups (Table S4).
你误解了吧。 这里说的是和 trial 无关的死亡，两边差不多是应该的
During the blinded, controlled period, 15 BNT162b2 and 14 placebo recipients died; during the open-label period, 3 BNT162b2 and 2 original placebo recipients who received BNT162b2 after unblinding died. None of these deaths were considered related to BNT162b2 by investigators. Causes of death were balanced between BNT162b2 and placebo groups (Table S4).
这是所有死亡，既有covid死也有其他死。反正就是死了-_-
我没找到Table S4， 什么找？ 很有兴趣看。
谢谢，有趣，不怎么看的懂。
那加上打了疫苗， 还没来得及二次感染新冠 但是因为疫苗本身产生严重副作用，或者心肌炎，血栓死掉的， 就扯平了吧
数据出处？
没数据扯不平，扯淡。
自己去ＶＡＥＲＳ 上看
从VAERS 上看，the benefit of the vaccine outweighs the risks.
Prove me wrong.